S. Harper et al., ANALYSIS OF THE NEUROTROPHIC EFFECTS OF GPI-1046 ON NEURON SURVIVAL AND REGENERATION IN CULTURE AND IN-VIVO, Neuroscience, 88(1), 1999, pp. 257-267
The putative neurotrophic effects of the immunophilin ligand GPI-1046
were evaluated in established experimental systems of neuron survival
and axon growth in vitro and in vivo. GPI-1046 marginally increased ne
urite outgrowth of chick dorsal root ganglia in culture under conditio
ns where a very robust effect of nerve growth factor was seen. GPI-104
6 failed to protect dopaminergic neurons from 1-methyl-1-phenylpyridin
ium in culture or to protect cultured cortical neurons from experiment
ally induced apoptosis in vitro. In adult rats in vivo, daily administ
ration of GPI-1046 (10 mg/kg, s.c.) for three days enhanced the maxima
l regeneration distance of both motor and large myelinated sensory axo
ns measured using an electrophysiological assay. However, derailed mor
phometric analysis of these animals failed to provide evidence for an
increase in axon numbers in GPI-1046-treated animals. The ability of G
PI-1046 to promote the recovery of dopaminergic function following uni
lateral 6-hydroxydopamine lesions of the substantia nigra was also tes
ted in rats. In the first study, the duration of amphetamine (3 mg/kg,
s.c.)-induced circling, but not the maximal number of rotations, was
significantly reduced in animals treated with GPI-1046 for five days (
10 mg/k/day). In a second study, testing the effects of delayed GPI-10
46 administration, chronic treatment with GPI-1046 (10 mg/kg/day) for
two weeks, beginning one month after surgery, did not alter circling r
esponses. Morphometric analysis failed to reveal any changes in either
the density of tyrosine hyroxylase-positive fibres in dopaminergic ta
rget areas or in cell numbers in the substantia nigra in both experime
nts. Thus, while GPI-1046 produced marginal effects on neurite outgrow
th in dorsal root ganglia cultures and on functional paramaters of ner
ve regeneration ill vivo; we failed to obtain evidence in support of t
he notion of a general neuroprotective effect of the compound or for a
n effect on morphologic nerve regeneration in vivo. (C) 1998 IBRO. Pub
lished by Elsevier Science Ltd.